Needham & Company LLC Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group (NASDAQ:PRVA) had its target price boosted by Needham & Company LLC from $25.00 to $30.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 17.83% from the stock’s current price.

Several other research firms have also issued reports on PRVA. Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price for the company. Truist Financial upped their price objective on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Stephens reiterated an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. JMP Securities reissued a “market outperform” rating and issued a $26.00 price target on shares of Privia Health Group in a report on Friday, February 14th. Finally, Barclays raised their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $25.50.

Privia Health Group Price Performance

PRVA opened at $25.46 on Friday. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04. The firm has a market capitalization of $3.06 billion, a P/E ratio of 254.63, a PEG ratio of 3.47 and a beta of 0.87. The company’s 50-day moving average is $22.30 and its 200 day moving average is $20.55.

Institutional Trading of Privia Health Group

Institutional investors and hedge funds have recently bought and sold shares of the company. First Horizon Advisors Inc. grew its position in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Privia Health Group by 7,833.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. bought a new position in Privia Health Group in the 4th quarter worth about $51,000. Quarry LP increased its stake in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after acquiring an additional 2,533 shares during the last quarter. Finally, KBC Group NV raised its holdings in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after acquiring an additional 871 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.